Skip to content

Clinical study on Tongjingning cataplasm combined with meridian theory of external treatment of traditional Chinese medicine in treating dysmenorrhea associated with endometriosis of blood stasis type

Clinical study on Tongjingning cataplasm combined with meridian theory of external treatment of traditional Chinese medicine in treating dysmenorrhea associated with endometriosis of blood stasis type

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043687
Enrollment
Unknown
Registered
2021-02-27
Start date
2021-11-01
Completion date
Unknown
Last updated
2021-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysmenorrhea secondary to endometriosis

Interventions

Sponsors

Shanghai Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 50 Years

Inclusion criteria

Inclusion criteria: (1) They were in accordance with the clinical or pathological diagnostic criteria of endometriosis; (2) It was consistent with the diagnostic criteria of blood stasis syndrome of endometriosis; (3) Non lactation patients aged 25-48 years old; (4) Regular menstrual cycle (menstrual cycle 21-35 days). (5) Voluntary informed consent.

Exclusion criteria

Exclusion criteria: (1) It was confirmed by examination that it was composed of gynecological tumor (except uterine fibroids less than 3cm), specific vaginitis (vulvovaginal Candida) In addition, there are many diseases, such as trichomonal vaginitis, bacterial vaginitis, adenomyosis, tuberculous pelvic inflammatory disease, pelvic abscess, pelvic mass and cervical disease Other diseases such as dysplasia cause related symptoms; (2) Absence of uterus and / or double appendages; (3) Pregnant or half a year pregnant women, lactating women; (4) They were complicated with serious primary diseases such as heart, cerebrovascular, liver, kidney and hematopoietic system, diabetes, thyroid diseases and mental disorders Patients with chronic hepatitis B; (5) Allergic constitution, as well as allergic to the relevant components of the drug; (6) Those who have participated in other clinical studies in the past month, or are taking similar drugs and related treatments in the past month, such as taking related drugs or Antagonistic drugs (such as antibiotics) make it difficult to judge the efficacy of drugs; (7) Suspected or confirmed to have a history of alcohol addiction or drug abuse, or according to the judgment of the researcher, with the possibility of reducing the enrollment or making the Other complicated diseases or conditions, such as frequent changes in working environment and unstable living environment, are likely to cause loss of follow-up; (8) The researcher thinks that it is not suitable to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Dysmenorrhea score;

Countries

China

Contacts

Public ContactChen Jing

Shanghai Hospital of Traditional Chinese Medicine

m15921440609@163.com+86 15921440609

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026